+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030- Product Image
Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716225
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell & Gene Therapy Market size was estimated at USD 27.70 billion in 2023, USD 34.63 billion in 2024, and is expected to grow at a CAGR of 25.39% to reach USD 135.04 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell & Gene Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell & Gene Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell & Gene Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Adaptimmune Limited, AGC Biologics, Alnylam Pharmaceuticals, Inc., American Gene Technologies Inc., Amgen Inc., AnGes, Inc., Astellas Gene Therapies, Beacon Therapeutics Limited, Biogen Inc., bluebird bio, Inc., Cellectis SA, Editas Medicine, Inc., F. Hoffmann-La Roche Ltd, Immuneel Therapeutics Private Limited, Ionis Pharmaceuticals, Inc., Merck KGaA, Mustang Bio, Inc., Novartis AG, Orchard Therapeutics PLC, Poseida Therapeutics, Inc., Sangamo Therapeutics, Inc., Sarepta Therapeutics, Inc., Sibiono GeneTech Co. Ltd., and Uniqure N.V.

Market Segmentation & Coverage

This research report categorizes the Cell & Gene Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cell Therapy
    • Gene Therapy
  • Delivery Method
    • Ex Vivo
    • In Vivo
  • Application
    • Dermatology
    • Musculoskeletal
    • Oncology
  • End-User
    • Ambulatory Surgical Centers
    • Cancer Care Centers
    • Hospitals
    • Wound Care Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cell & Gene Therapy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell & Gene Therapy Market?
  3. What are the technology trends and regulatory frameworks in the Cell & Gene Therapy Market?
  4. What is the market share of the leading vendors in the Cell & Gene Therapy Market?
  5. Which modes and strategic moves are suitable for entering the Cell & Gene Therapy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell & Gene Therapy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases and significance for gene therapy treatment
5.1.1.2. Growing awareness of gene & cell therapies coupled with increase in healthcare expenditure
5.1.1.3. Significant growth in numbers of clinical trials and increasing governmental approvals
5.1.2. Restraints
5.1.2.1. High costs asscoiated with the gene and cell therapy treatment
5.1.3. Opportunities
5.1.3.1. Emergence of advanced analytical technologies in development of cell & gene
5.1.3.2. Rising investments in pharmaceutical and biopharmaceutical research
5.1.4. Challenges
5.1.4.1. Unavailability of reimbursement policies for cell & gene therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell & Gene Therapy Market, by Product
6.1. Introduction
6.2. Cell Therapy
6.3. Gene Therapy
7. Cell & Gene Therapy Market, by Delivery Method
7.1. Introduction
7.2. Ex Vivo
7.3. In Vivo
8. Cell & Gene Therapy Market, by Application
8.1. Introduction
8.2. Dermatology
8.3. Musculoskeletal
8.4. Oncology
9. Cell & Gene Therapy Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Cancer Care Centers
9.4. Hospitals
9.5. Wound Care Centers
10. Americas Cell & Gene Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell & Gene Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell & Gene Therapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abeona Therapeutics Inc.
14.1.2. Adaptimmune Limited
14.1.3. AGC Biologics
14.1.4. Alnylam Pharmaceuticals, Inc.
14.1.5. American Gene Technologies Inc.
14.1.6. Amgen Inc.
14.1.7. AnGes, Inc.
14.1.8. Astellas Gene Therapies
14.1.9. Beacon Therapeutics Limited
14.1.10. Biogen Inc.
14.1.11. bluebird bio, Inc.
14.1.12. Cellectis SA
14.1.13. Editas Medicine, Inc.
14.1.14. F. Hoffmann-La Roche Ltd
14.1.15. Immuneel Therapeutics Private Limited
14.1.16. Ionis Pharmaceuticals, Inc.
14.1.17. Merck KGaA
14.1.18. Mustang Bio, Inc.
14.1.19. Novartis AG
14.1.20. Orchard Therapeutics PLC
14.1.21. Poseida Therapeutics, Inc.
14.1.22. Sangamo Therapeutics, Inc.
14.1.23. Sarepta Therapeutics, Inc.
14.1.24. Sibiono GeneTech Co. Ltd.
14.1.25. Uniqure N.V.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CELL & GENE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. CELL & GENE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL & GENE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL & GENE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL & GENE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL & GENE THERAPY MARKET DYNAMICS
FIGURE 7. CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
FIGURE 10. CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL & GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CELL & GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CELL & GENE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CELL & GENE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 9. CELL & GENE THERAPY MARKET SIZE, BY EX VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL & GENE THERAPY MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. CELL & GENE THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELL & GENE THERAPY MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. CELL & GENE THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CELL & GENE THERAPY MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL & GENE THERAPY MARKET SIZE, BY WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. CANADA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 35. CANADA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. MEXICO CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CHINA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 57. CHINA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. INDIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 61. INDIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. JAPAN CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. THAILAND CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. DENMARK CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. EGYPT CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. FINLAND CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ITALY CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 130. ITALY CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NORWAY CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. POLAND CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 146. POLAND CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. QATAR CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 150. QATAR CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. TURKEY CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CELL & GENE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CELL & GENE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. CELL & GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. CELL & GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. CELL & GENE THERAPY MARKET LICENSE & PRICING

Companies Mentioned

  • Abeona Therapeutics Inc.
  • Adaptimmune Limited
  • AGC Biologics
  • Alnylam Pharmaceuticals, Inc.
  • American Gene Technologies Inc.
  • Amgen Inc.
  • AnGes, Inc.
  • Astellas Gene Therapies
  • Beacon Therapeutics Limited
  • Biogen Inc.
  • bluebird bio, Inc.
  • Cellectis SA
  • Editas Medicine, Inc.
  • F. Hoffmann-La Roche Ltd
  • Immuneel Therapeutics Private Limited
  • Ionis Pharmaceuticals, Inc.
  • Merck KGaA
  • Mustang Bio, Inc.
  • Novartis AG
  • Orchard Therapeutics PLC
  • Poseida Therapeutics, Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Sibiono GeneTech Co. Ltd.
  • Uniqure N.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 34.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 135.04 Billion
Compound Annual Growth Rate25.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 175 Pages
  • Global
From
Global Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), Vector Type (Lentivirus, Adenovirus), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), Vector Type (Lentivirus, Adenovirus), Region, and Segment Forecasts, 2024-2030

  • Report
  • 162 Pages
  • Global
From
Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028 - Product Image

Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028

  • Report
  • 276 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.